A novel reactor configuration for continuous virus inactivation
Publication: Biochemical Engineering Journal
Palladium‐Catalyzed Reductive Carbonylation of (Hetero) Aryl Halides and Triflates Using Cobalt Carbonyl as CO Source
Publication: Europen Journal of Organic Chemistry
Lead Optimization of a Pyrrole-Based Dihydroorotate
Publication: Journal of Medicinal Chemistry
How Syngene helped develop the world’s first drug for a rare disease affecting children
Learn how Syngene partnered with a U.S.-based biotech company to develop and manufacture a first-in-class treatment for a rare disease affecting children.
Accelerating PROTAC programs to drug the “undruggable”
Syngene offers expertise in all aspects of PROTACs – from designing of small molecules to their synthesis, lead optimization, and ultimate candidate delivery at an accelerated pace.
Sterile Fill-Finish facility: Your integrated partner for customized clinical supplies
Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for clinical supply of sterile drug products having short development timelines.
ADME/PK profiling capabilities
Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.
How Syngene helped Panbela achieve shorter production time for its pancreatic cancer drug
Learn how Syngene streamlined the production process of Panbela’s pancreatic cancer drug, SBP-101, while ensuring high chiral purity of 98% during GMP manufacturing
Chemistry process research lab for Drug Discovery
Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.
SynVantage AI-enhanced relay-based drug discovery for optimizing Design-Make-Test-Analyze (DMTA) cycle
SynVantage is Syngene’s platform that enables a continuous and seamless transition between different stages of a DMTA cycle thereby reducing timelines for early drug discovery.